Genzyme Corporation dba Genzyme Therapeutics Division
- View government funding actions
- Cambridge, MA 021421108
- Phone: 508-271-2992
- Corporate URL: www.genzyme.com
- Estimated Number of Employees: 10,000
- Estimated Annual Receipts: $3,868,000,000
- Business Start Date: 1981
- Contact Person: Kurt Kober
- Contact Phone: 908-981-6390
- Contact Email: kurt.kober@sanofi.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Industries Served: Pharmaceutical Preparation Manufacturing
- Product Areas: DRUGS AND BIOLOGICALS
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $99,999 - Monday the 3rd of December 2012
Veterans Affairs Department
642-PHILADELPHIA
OTHER FUNCTIONS - SPECIALIZED ANATOMIS PATHOLOGY TESTING - $9,000 - Wednesday the 25th of May 2016
Veterans Affairs Department
437-FARGO VA MEDICAL CENTER
1ST QUARTER FEE BASIS TESTING - $8,846 - Friday the 30th of December 2011
Veterans Affairs Department
598-NORTH LITTLE ROCK
POUCHES - $88,000 - Monday the 13th of February 2012
Veterans Affairs Department
243-NETWORK CONTRACTING OFFICE 03
LABORATORY COST-PER-TEST - $7,710 - Wednesday the 25th of May 2016
Veterans Affairs Department
69D-NETWORK CONTRACT OFFICE 12
PROSTHETIC ORDERS - $7,500 - Thursday the 19th of June 2014
Veterans Affairs Department
549-DALLAS
LAB TESTING OPTION PERIOD II - $5,180 - Wednesday the 4th of January 2012
Veterans Affairs Department
506-ANN ARBOR
SEPRAFILM FOR SURGERY - $5,140 - Thursday the 10th of November 2011
Veterans Affairs Department
660-SALT LAKE CITY
ADHESION BARRIER, SEPRA FILM - $48,000 - Friday the 28th of September 2012
Veterans Affairs Department
243-NETWORK CONTRACTING OFFICE 03
AMENDMET INCREASE IS FOR $48,000 FOR THE CONTINUATION OF LABORATORY SERVICES THAT WILL BE USED TO ASSIST IN THE TREATMENT OF OUR VETERANS. - $3,290 - Thursday the 4th of October 2012
Veterans Affairs Department
246-NETWORK CONTRACTING OFFICE 6
SEPRAFILM FOR THE OR
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.